Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Ciprofloxacin ear infection?Keytruda patent expiry and generic filing or anda and biosimilar and 2024 or 2025 or 2026?Mounjaro patent expiry uk tirzepatide patent expiry?Semaglutide patent status expiration china generics impact 2024 2025?Skyrizi loss of exclusivity date?
See the DrugPatentWatch profile for butalbital
Yes. Butalbital is regulated as a controlled substance in the United States. It is commonly found in combination pain medicines (often with acetaminophen and/or caffeine), and those products are controlled because of the barbiturate component.
Butalbital is generally classified as a Schedule III controlled substance (based on its status as a barbiturate used in certain prescription combination products).
Yes. Butalbital’s controlled status applies to products containing butalbital, such as prescription combination formulations. The control status depends on the specific drug formulation and how it is scheduled by regulators.
Barbiturates like butalbital have abuse and dependence potential, which is why they are scheduled and subject to prescription and dispensing controls.
For the most accurate, product-specific scheduling and related drug information, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Butalbital :